Charles Schwab’s Chimerix, Inc. CMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,437
| Closed | -$302K | – | 3613 |
|
|
2025
Q1 | $302K | Sell |
35,437
-17,220
| -33% | -$95K | ﹤0.01% | 3206 |
|
|
2024
Q4 | $183K | Buy |
+52,657
| New | +$74.3K | ﹤0.01% | 3341 |
|
|
2023
Q3 | – | Sell |
-37,732
| Closed | -$45.7K | – | 3640 |
|
|
2023
Q2 | $45.7K | Sell |
37,732
-192,052
| -84% | -$243K | ﹤0.01% | 3431 |
|
|
2023
Q1 | $290K | Hold |
229,784
| – | – | ﹤0.01% | 3098 |
|
|
2022
Q4 | $427K | Buy |
229,784
+7,421
| +3% | +$14.5K | ﹤0.01% | 3041 |
|
|
2022
Q3 | $430K | Sell |
222,363
-279,151
| -56% | -$626K | ﹤0.01% | 3045 |
|
|
2022
Q2 | $1.04M | Sell |
501,514
-26,562
| -5% | -$85.3K | ﹤0.01% | 2777 |
|
|
2022
Q1 | $2.42M | Sell |
528,076
-28,504
| -5% | -$159K | ﹤0.01% | 2582 |
|
|
2021
Q4 | $3.58M | Buy |
556,580
+11,987
| +2% | +$71.9K | ﹤0.01% | 2518 |
|
|
2021
Q3 | $3.37M | Sell |
544,593
-2,026
| -0.4% | -$13.9K | ﹤0.01% | 2562 |
|
|
2021
Q2 | $4.37M | Buy |
546,619
+36,810
| +7% | +$306K | ﹤0.01% | 2416 |
|
|
2021
Q1 | $4.92M | Buy |
509,809
+195,025
| +62% | +$1.79M | ﹤0.01% | 2312 |
|
|
2020
Q4 | $1.52M | Buy |
314,784
+7,077
| +2% | +$25.7K | ﹤0.01% | 2677 |
|
|
2020
Q3 | $767K | Sell |
307,707
-11,878
| -4% | -$35.1K | ﹤0.01% | 2740 |
|
|
2020
Q2 | $991K | Buy |
319,585
+4,714
| +1% | +$12.2K | ﹤0.01% | 2629 |
|
|
2020
Q1 | $454K | Buy |
314,871
+4,604
| +1% | +$8.06K | ﹤0.01% | 2747 |
|
|
2019
Q4 | $630K | Buy |
310,267
+47,738
| +18% | +$88K | ﹤0.01% | 2736 |
|
|
2019
Q3 | $617K | Sell |
262,529
-13,175
| -5% | -$38K | ﹤0.01% | 2718 |
|
|
2019
Q2 | $1.19M | Buy |
275,704
+28,387
| +11% | +$87.3K | ﹤0.01% | 2515 |
|
|
2019
Q1 | $520K | Sell |
247,317
-94
| -0% | -$214 | ﹤0.01% | 2753 |
|
|
2018
Q4 | $636K | Sell |
247,411
-2,444
| -1% | -$8.18K | ﹤0.01% | 2680 |
|
|
2018
Q3 | $972K | Buy |
249,855
+26,666
| +12% | +$114K | ﹤0.01% | 2639 |
|
|
2018
Q2 | $1.06M | Buy |
223,189
+35,216
| +19% | +$168K | ﹤0.01% | 2569 |
|
|
2018
Q1 | $978K | Sell |
187,973
-23,682
| -11% | -$120K | ﹤0.01% | 2522 |
|
|
2017
Q4 | $980K | Buy |
211,655
+10,764
| +5% | +$51.2K | ﹤0.01% | 2512 |
|
|
2017
Q3 | $1.05M | Buy |
200,891
+106,267
| +112% | +$523K | ﹤0.01% | 2495 |
|
|
2017
Q2 | $516K | Sell |
94,624
-39,297
| -29% | -$207K | ﹤0.01% | 2683 |
|
|
2017
Q1 | $855K | Buy |
133,921
+6,327
| +5% | +$35.9K | ﹤0.01% | 2471 |
|
|
2016
Q4 | $587K | Buy |
127,594
+5,698
| +5% | +$26.9K | ﹤0.01% | 2601 |
|
|
2016
Q3 | $676K | Buy |
121,896
+42,310
| +53% | +$194K | ﹤0.01% | 2519 |
|
|
2016
Q2 | $313K | Sell |
79,586
-56,479
| -42% | -$279K | ﹤0.01% | 2769 |
|
|
2016
Q1 | $696K | Sell |
136,065
-5,116
| -4% | -$33.4K | ﹤0.01% | 2462 |
|
|
2015
Q4 | $1.26M | Buy |
141,181
+6,847
| +5% | +$247K | ﹤0.01% | 2286 |
|
|
2015
Q3 | $5.13M | Buy |
134,334
+17,809
| +15% | +$880K | 0.01% | 1454 |
|
|
2015
Q2 | $5.38M | Buy |
116,525
+23,740
| +26% | +$952K | 0.01% | 1506 |
|
|
2015
Q1 | $3.5M | Buy |
92,785
+4,685
| +5% | +$186K | ﹤0.01% | 1740 |
|
|
2014
Q4 | $3.55M | Buy |
88,100
+16,482
| +23% | +$558K | 0.01% | 1685 |
|
|
2014
Q3 | $1.98M | Buy |
71,618
+6,905
| +11% | +$168K | ﹤0.01% | 1975 |
|
|
2014
Q2 | $1.42M | Buy |
64,713
+42,467
| +191% | +$843K | ﹤0.01% | 2161 |
|
|
2014
Q1 | $509K | Buy |
22,246
+780
| +4% | +$15.7K | ﹤0.01% | 2578 |
|
|
2013
Q4 | $325K | Buy |
21,466
+936
| +5% | +$14.9K | ﹤0.01% | 2767 |
|
|
2013
Q3 | $448K | Buy |
20,530
+5,080
| +33% | +$105K | ﹤0.01% | 2593 |
|
|
2013
Q2 | $375K | Buy |
+15,450
| New | +$323K | ﹤0.01% | 2641 |
|
Other funds holding CMRX
Charles Schwab's CMRX Position: Q2 2025 in Review
Charles Schwab sold out of Chimerix, Inc. (CMRX) in Q2 2025, closing a stake of 35,437 shares — an estimated $302K sold.
Charles Schwab first reported a position in CMRX in Q2 2013 and held it in 43 quarters. The position peaked at $5.38M in Q2 2015. 1 fund tracked by Wall St. Rank holds CMRX as of Q2 2025.
- Charles Schwab reported no remaining Chimerix, Inc. position as of Q2 2025 after selling out during the quarter.
- Charles Schwab sold 35,437 Chimerix, Inc. shares in Q2 2025, an estimated $302K.
- Charles Schwab first reported a position in Chimerix, Inc. in Q2 2013 and held it in 43 quarters.
- Charles Schwab's Chimerix, Inc. position peaked at $5.38M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2025.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.